White House, weight loss drugs
Digest more
Everyday Health on MSN
White House Slashes GLP-1 Costs, Permits Medicare Coverage for Obesity
A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist.
TrumpRx will offer Novo Nordisk's Ozempic and Wegovy through TrumpRx for $350 and Eli Lilly and Company's Zepbound and orforglipron, if approved by the FDA, for $346.
President Donald Trump had a jump scare at the White House when a man collapsed while standing just behind him during an event in the Oval Office.
A White House guest collapsed behind President Trump during an Oval Office press conference, leading to an abrupt pause in coverage. A spokesperson from Eli Lilly said the man experienced a 'medical situation.
Ahead of a reported White House deal meant to lower the cost of obesity drugs like Wegovy, Novo said “intensifying competition and pricing pressure” led it to lower its yearly sales projections.